The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Group Regulatory News (PGH)

Share Price Information for Personal Group (PGH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 160.00
Ask: 165.00
Change: 1.00 (0.62%)
Spread: 5.00 (3.125%)
Open: 161.50
High: 162.50
Low: 161.50
Prev. Close: 161.50
PGH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealing

25 Sep 2019 08:09

RNS Number : 5990N
Personal Group Holdings PLC
25 September 2019
 

25 September 2019

 

 

 

Personal Group Holdings Plc

 

("the Company")

 

 

Director/PDMR Dealing

 

The Company has been informed by Mike Dugdale, Chief Financial Officer, that he has purchased, on 23 September 2019, 1,168 ordinary shares of 5 pence each in the Company at a price of £3.5075 per share.

 

Following this transaction, Mr Dugdale has an interest in 41,353 ordinary shares of 5p each in the Company, including his wife's holding of 18,069 shares. This represents in aggregate 0.132% of the issued ordinary share capital of the Company.

 

Further detail is provided below in accordance with Article 19.3 of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mike Dugdale

 

2

 

Reason for the notification

 

a)

 

Position/status

CFO

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Personal Group Holdings Plc

b)

 

LEI

 

213800TN8BH2YYWAH345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5p each

 

 

ISIN: GB0002760279

 

 

 

b)

 

Nature of the transaction

 

Purchase of shares

 

 

c)

 

 

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.5075 per share

1,168

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

1,168

 

 

£3.5075

 

 

e)

 

Date of the transaction

 

23 September 2019

f)

 

Place of the transaction

 

London Stock Exchange

 

 

 

- ENDS -

 

For more information please contact:

 

Personal Group Holdings Plc

Deborah Frost / Mike Dugdale

+44 (0)1908 605 000

Cenkos Securities Plc

Max Hartley / Stephen Keys (Nomad)

+44 (0)20 7397 8900

Russell Kerr (Sales)

Hudson Sandler

Nick Lyon / Lucy Wollam

+44 (0)20 7796 4133

 

Notes to Editors:

Personal Group Holdings Plc (AIM: PGH) is a technology enabled employee services business, working with employers to drive productivity though better employee engagement and a more motivated workforce. With over 30 years' experience, the Company provides employee benefits and services to a large number of employees across the UK.

Personal Group's offer comprises in-house services, including employee insurance products (hospital, convalescence plans and death benefit), the provision of home technology via salary sacrifice (iPads, computers, laptops, smart phones and smart TVs), the provision of e-payslips, and pay and reward consulting via Innecto, the leading independent UK consultancy acquired in 2019. Third party services include retail discounts, employee assistance programmes, wellbeing programmes and salary sacrifice cars and bikes.

The product offer is provided via the Company's proprietary technology platform, Hapi. The platform is intuitive, designed primarily for app deployment and also accessible via web and tablet, driving better engagement, communication and value recognition. Hapi is flexible and can quickly integrate additional services, such as existing employee services and partner platforms. Hapi is a digital SaaS product.

Through technology and select acquisitions, the Company has grown its addressable market to the majority of the working population in the UK; including 15.6m SME employees targeted via its partnership with Sage, the UK's largest software company.

Personal Group's innovative approach to using technology to deliver its programmes, in combination with its face-to-face method of communicating with employees, delivers a compelling offer to blue-chip clients across the UK as a way of attracting, retaining and motivating employees. The acquisition of Innecto in February 2019 allows Personal Group to engage with clients earlier in their thinking around Pay and Reward, and to interact with a new base of blue-chip and fast growth clients typically at HR Director and CEO level.

Personal Group has a strong client base across a range of sectors including passenger transport, healthcare, logistics and food manufacturing. Clients include: Stagecoach, Four Seasons Health Care, DHL, and 2 Sisters Food Group.

For further information, please see www.personalgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDELBLKKFBBBD
Date   Source Headline
22nd Apr 20247:00 amRNSPurchase of shares by Employee Benefit Trust
18th Apr 20242:56 pmRNSPurchase of shares by Employee Benefit Trust
11th Apr 20249:28 amRNSDirector/PDMR Shareholding
5th Apr 202411:00 amRNSNotice of AGM
5th Apr 20247:00 amRNSGrant of LTIP & CSOP Options
20th Mar 20248:00 amRNSReplacement:Preliminary Results and Final Dividend
19th Mar 20247:01 amRNSGlobal Airline Selects Personal Group
19th Mar 20247:00 amRNSPreliminary Results and Final Dividend
14th Mar 20247:00 amRNSNotice of Results Presentations
25th Jan 20247:00 amRNSTrading Update and Notice of Results
17th Jan 20242:21 pmRNSDirector/PDMR Dealings
4th Jan 20245:38 pmRNSPDMR Share Dealing
18th Dec 20234:25 pmRNSDirector/PDMR Dealings
13th Dec 20234:48 pmRNSHolding(s) in Company
29th Nov 202310:37 amRNSChange of Nominated Adviser and Broker
29th Sep 20237:00 amRNSInterim Results
25th Sep 20237:00 amRNSNotification of Major Holdings
4th Sep 20237:00 amRNSNotice of Results
10th Aug 20236:09 pmRNSGrant of LTIP options
19th Jul 20233:40 pmRNSTrading Update & Update on CEO Transition-Amend
19th Jul 20237:00 amRNSTrading Update and Update on CEO Transition
10th Jul 20231:42 pmRNSPDMR Share Dealing
21st Jun 20237:00 amRNSGrant of LTIP & CSOP options
4th May 202311:30 amRNSResults of Annual General Meeting
4th May 202311:18 amRNSNotification of Major Holdings
4th May 20237:01 amRNSAGM Statement
4th May 20237:00 amRNSCEO Succession
21st Apr 20232:32 pmRNSAGM Notification Amendment
11th Apr 20233:36 pmRNSAGM Notification
28th Mar 20237:00 amRNSPreliminary Results and Final Dividend
13th Mar 20237:00 amRNSNotice of Results Presentations
30th Jan 20237:00 amRNSTrading Update
4th Jan 20232:33 pmRNSPDMR Share Dealing
27th Sep 20227:00 amRNSInterim Results
19th Aug 20227:00 amRNSNotice of Analyst and Investor Presentations
26th Jul 20227:00 amRNSTrading Update and Notice of Results
5th Jul 20227:00 amRNSPDMR Share Dealing
1st Jul 20227:00 amRNSAcquisition of Quintige Consulting Group Limited
16th Jun 20227:00 amRNSDirector's Dealings
9th Jun 20229:32 amRNSExercise of Share Options, PDMR Dealings and TVR
1st Jun 20227:00 amRNSDirectorate Change
24th May 20227:00 amRNSDirectorate Change
5th May 20225:00 pmRNSResults of Annual General Meeting
5th May 20227:00 amRNSAGM Statement
20th Apr 20227:00 amRNSLong Term Incentive Plan Awards
12th Apr 202211:06 amRNSAGM Notification
4th Apr 20227:00 amRNSPurchase of shares by Employee Benefit Trust
29th Mar 20227:00 amRNSPreliminary Results and Final Dividend
2nd Mar 20227:00 amRNSAppointment of Chief Wellbeing Ambassador
28th Feb 20223:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.